Metabolic changes in protease inhibitor-naive patients treated for 1 year with lopinavir/ritonavir.
Galindo
Maria José
MJ
Verdejo
José
J
Gonzalez-Muñoz
Miguel
M
Ferrer
Ana
A
Polo
Rosa
R
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D018791:CD4 Lymphocyte Count; D002318:Cardiovascular Diseases / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood*; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000627:therapeutic use*; D012307:Risk Factors; D019438:Ritonavir / Q000627:therapeutic use*
D001786:Blood Glucose; D017320:HIV Protease Inhibitors; D008055:Lipids; D011744:Pyrimidinones; D061466:Lopinavir; D002784:Cholesterol; D019438:Ritonavir